Operator
Welcome to the Cardiff Oncology Onvansertib Information Replace Name. [Operator Instructions] Please be suggested that as we speak’s convention is being recorded. I might now like to show the convention over to Candice Masse of Astr Companions. Please go forward.
Mani Mohindru
Thanks, operator. That is Mani Mohindru from Cardiff. Given the technical difficulties, I will take over. Becoming a member of the decision as we speak with me from the Cardiff Oncology staff will probably be me, myself, the Interim CEO. As well as, I am joined with my Chief Medical Officer, Dr. Roger Sidhu; our Chief Scientific Officer, Dr. Tod Smeal; and our newly promoted Chief Accounting Officer, Ms. Brigitte Lindsay, and also will be obtainable through the Q&A session.
Throughout this convention name, we will probably be making forward-looking statements, together with, with out limitation, statements associated to steerage, outcomes and the timing of knowledge readouts for onvansertib scientific research. These forward-looking statements are primarily based on the corporate’s present expectations and inherently contain important dangers and uncertainties. Our precise outcomes and the timing of the occasions might differ materially from these anticipated in such forward-looking statements because of these dangers and uncertainties.
Components that would trigger outcomes to be totally different from these statements embrace elements that the
